Publicacións nas que colabora con Sonia Eiras Penas (22)

2024

  1. Accumulation of Inflammatory Mediators in the Normal Pericardial Fluid

    International Journal of Molecular Sciences, Vol. 25, Núm. 1

  2. Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation

    Journal of Cardiovascular Translational Research, Vol. 17, Núm. 1, pp. 13-23

2023

  1. Clinical Profiling and Biomarkers for Post-Operative Atrial Fibrillation Prediction in Patients Undergoing Cardiac Surgery

    Journal of Clinical Medicine, Vol. 12, Núm. 10

2022

  1. Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue-molecules and SGLT2i dapagliflozin

    Journal of Cellular and Molecular Medicine, Vol. 26, Núm. 16, pp. 4416-4427

  2. The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure

    Cells, Vol. 11, Núm. 8

2020

  1. CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure

    Frontiers in Physiology, Vol. 11

  2. High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment

    Atherosclerosis, Vol. 292, pp. 60-69

  3. Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open-heart surgery

    Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 18, pp. 10958-10969

2019

  1. Cholinergic activity regulates the secretome of epicardial adipose tissue: Association with atrial fibrillation

    Journal of Cellular Physiology, Vol. 234, Núm. 7, pp. 10512-10522

  2. Plasma FABP4 levels are associated with left atrial fat volume in persistent atrial fibrillation and predict recurrence after catheter ablation

    International Journal of Cardiology, Vol. 292, pp. 131-135

2018

  1. Effects of dapagliflozin on human epicardial adipose tissue: Modulation of insulin resistance, inflammatory chemokine production, and differentiation ability

    Cardiovascular Research, Vol. 114, Núm. 2, pp. 336-346

2017

  1. Omentin treatment of epicardial fat improves its anti-inflammatory activity and paracrine benefit on smooth muscle cells

    Obesity, Vol. 25, Núm. 6, pp. 1042-1049

2016

  1. Glucose and Inflammatory Cells Decrease Adiponectin in Epicardial Adipose Tissue Cells: Paracrine Consequences on Vascular Endothelium

    Journal of Cellular Physiology, Vol. 231, Núm. 5, pp. 1015-1023

  2. Sea cucumbers with an anti-inflammatory effect on endothelial cells and subcutaneous but not on epicardial adipose tissue

    Food and Function, Vol. 7, Núm. 2, pp. 953-963

2015

  1. Orosomucoid secretion levels by epicardial adipose tissue as possible indicator of endothelial dysfunction in diabetes mellitus or inflammation in coronary artery disease

    Atherosclerosis, Vol. 235, Núm. 2, pp. 281-288

2014

  1. Impaired Adipogenesis and Insulin Resistance in Epicardial Fat-Mesenchymal Cells From Patients With Cardiovascular Disease

    Journal of Cellular Physiology, Vol. 229, Núm. 11, pp. 1722-1730

2012

  1. Changes in lipid transport-involved proteins of epicardial adipose tissue associated with coronary artery disease

    Atherosclerosis, Vol. 224, Núm. 2, pp. 492-499

  2. Estudios del secretoma y proteoma de grasa epicárdica han determinado niveles de proteínas implicadas en el transporte de lípidos más bajos en pacientes con cardiopatía isquémica

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 106-106

2010

  1. Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 299, Núm. 1

2008

  1. Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension

    Journal of Human Hypertension, Vol. 22, Núm. 12, pp. 856-863